Form 8-K - Current report:
SEC Accession No. 0001493152-24-026379
Filing Date
2024-07-05
Accepted
2024-07-05 16:45:11
Documents
18
Period of Report
2024-06-30
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 42003
2 ex10-1.htm EX-10.1 22544
3 ex10-2.htm EX-10.2 21738
4 ex10-3.htm EX-10.3 21790
5 ex10-4.htm EX-10.4 21734
6 ex10-5.htm EX-10.5 21936
  Complete submission text file 0001493152-24-026379.txt   337998

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE arth-20240630.xsd EX-101.SCH 3039
8 XBRL LABEL FILE arth-20240630_lab.xml EX-101.LAB 34240
9 XBRL PRESENTATION FILE arth-20240630_pre.xml EX-101.PRE 22375
20 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3354
Mailing Address 235 WALNUT STREET, SUITE 6 FRAMINGHAM MA 01702
Business Address 235 WALNUT STREET, SUITE 6 FRAMINGHAM MA 01702 617-431-2313
Arch Therapeutics, Inc. (Filer) CIK: 0001537561 (see all company filings)

EIN.: 460524102 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 000-54986 | Film No.: 241102951
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)